Achieve Life Sciences
ACHV • NASDAQ
Achieve Life Sciences is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Richard A. Stewart, with a market cap of $141.1M.
CEORichard A. Stewart
Next Earnings
Upcoming earnings announcement for Achieve Life Sciences
Date
Tuesday, May 12, 2026 (in a month)
Timing
Before Market Open (7:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.30
Earnings History
Past 12 earnings reports for Achieve Life Sciences
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 24, 2026 | Q4 2025 | -$0.28Est: -$0.27 | -3.7% | - | — |  10-K |
| Nov 6, 2025 | Q3 2025 | -$0.28Est: -$0.25 | -12.0% | - | — | 10-Q |
| Aug 7, 2025 | Q2 2025 | -$0.37Est: -$0.36 | -2.8% | - | — | 10-Q |
| May 13, 2025 | Q1 2025 | -$0.37Est: -$0.37 | 0.0% | - | — | 10-Q |
| Mar 11, 2025 | Q4 2024 | -$0.36Est: -$0.36 | 0.0% | - | — | 10-K |
| Nov 7, 2024 | Q3 2024 | -$0.36Est: -$0.26 | -38.5% | - | — | 10-Q |
| Aug 13, 2024 | Q2 2024 | -$0.25Est: -$0.23 | -8.7% | - | — | 10-Q |
| May 9, 2024 | Q1 2024 | -$0.26Est: -$0.23 | -13.0% | - | — | 10-Q |
| Mar 28, 2024 | Q4 2023 | -$0.26Est: -$0.31 | +16.1% | - | — | 10-K |
| Nov 9, 2023 | Q3 2023 | -$0.34Est: -$0.38 | +10.5% | - | — | — |
| Aug 14, 2023 | Q2 2023 | -$0.43Est: -$0.42 | -2.4% | - | — | 10-Q |
| May 9, 2023 | Q1 2023 | -$0.50Est: -$0.69 | +27.5% | - | — | — |